Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000352840

Medchemexpress LLC N-Mal-N-bis(PEG2-NHS ester) | 2182601-73-4 | 98.9% | C29H38N4O15 | 25 MG
SDP

Catalog No. 5000352840
Encompass_Preferred

N-Mal-N-bis(PEG2-NHS ester) is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. PROTACs employ two distinct ligands connected by a linker; one ligand targets an E3 ubiquitin ligase, and the other targets a specific protein. These compounds leverage the intracellular ubiquitin-proteasome system for selective degradation of target proteins. This product is for research use only.

  • PEG-based PROTAC linker
  • Supports synthesis of PROTACs
  • Exploits ubiquitin-proteasome system
  • Enables selective degradation of target proteins
  • Store at -20°C, protected from light and under nitrogen
  • Soluble in DMSO (100 mg/mL)

Catalog No. 50-003-52840 Supplier Medchemexpress LLC Supplier No. 25MGHY140571
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

N-Mal-N-bis(PEG2-NHS ester) is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. PROTACs employ two distinct ligands connected by a linker; one ligand targets an E3 ubiquitin ligase, and the other targets a specific protein. These compounds leverage the intracellular ubiquitin-proteasome system for selective degradation of target proteins. This product is for research use only.

  • PEG-based PROTAC linker
  • Supports synthesis of PROTACs
  • Exploits ubiquitin-proteasome system
  • Enables selective degradation of target proteins
  • Store at -20°C, protected from light and under nitrogen
  • Soluble in DMSO (100 mg/mL)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.